U.S. To Invest $170M In Completing Research On Experimental Ebola Vaccines, Drugs

Reuters: U.S. invests $170 million in late-stage Ebola vaccines, drugs “The U.S. government is investing more than $170 million to help two new vaccines against the Ebola virus and two Ebola drugs complete the steps needed for approval from the Food and Drug Administration. The Biomedical Advanced Research and Development Authority (BARDA), part of the…More

Read this article:
U.S. To Invest $170M In Completing Research On Experimental Ebola Vaccines, Drugs